Bernstein cuts Criteo stock price target to $35 on outlook cut

Bernstein SocGen cut Criteo’s price target to $35 from $43 while keeping an Outperform rating, after the stock dropped 20% on May 6 when management cut fiscal 2026 outlook by 3%. The shares are now near the 52-week low of $15.57, trading around 2.07x EV/EBITDA and 9.35x earnings, which Bernstein says leaves meaningful upside versus current levels. Q1 2026 results were strong, with EPS of $0.73 versus $0.57 expected and revenue of $425 million versus $248.16 million, but the stock still fell 13.02% premarket to $17.50 amid investor concerns.

Analysis

The market is treating CRTO like a clean guidance miss, but the deeper issue is multiple compression in a structurally cyclical ad-tech name with weak visibility. When a stock rerates to low-teens EV/EBITDA, the next leg is usually driven less by fundamentals and more by whether investors regain confidence that revenue can re-accelerate on a 2-3 quarter lag; until then, even good prints can be sold. The fact that the shares are pricing a recession-like outcome while the business still shows operating leverage creates a setup where small changes in growth expectations can move the equity disproportionately.

Second-order, the AI narrative cuts both ways. If Criteo’s commerce data remains relevant to AI-driven ad allocation, that is a strategic asset, but it also raises the bar for proof: buyers will want evidence that large platforms and in-house retail media stacks are not eroding its role as an intermediary. The more important catalyst is not headline EPS, but whether management can stabilize client cohorts and demonstrate that last year’s churn is truly rolling off before macro weakness compounds the issue.

The contrarian view is that the selloff may be overdone relative to the operating base. At this valuation, the market is effectively assuming persistent decay, so any normalization in ad budgets, improved retail media monetization, or a less punitive 2026 guide could trigger a fast re-rating. The risk is that value traps often look cheapest right before another step-down in estimates; if the next two quarters show no evidence of retention improvement, the low multiple can stay low for a long time.

Key Decisions for Investors

• Long CRTO for a 3-6 month mean-reversion trade, but only on confirmation of stabilization in quarterly commentary; target a move back toward 4-5x EV/EBITDA if growth stops deteriorating, with downside capped by setting a hard stop if forward guidance is reduced again.
• Buy CRTO call spreads 3-6 months out rather than outright stock; the setup favors convexity because the stock is pricing a severe disappointment, while the main risk is another estimate reset that can be defined to the premium paid.
• Pair trade: long CRTO / short a higher-multiple ad-tech or digital advertising proxy over the next 1-2 quarters to isolate idiosyncratic re-rating if the market eventually rewards the valuation gap rather than sector beta.
• If already long, hedge with a short-dated put against the next earnings event; this name is vulnerable to gap risk on guidance, and implied volatility is likely cheaper than the damage from another 15-20% drawdown.
• Avoid chasing the rebound until there is evidence that client attrition has bottomed; the risk/reward improves materially only after the market sees one quarter where management stops talking about lagged headwinds and starts talking about incremental demand.